Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06960317 · ClinicalTrials.gov registry record · NA
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
A NA study of Contraception and Pain, Acute, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 1
- Study location
NCT06960317 is a NA study of Contraception and Pain, Acute that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 204 participants, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06960317, a NA study of Contraception and Pain, Acute, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this research study is to learn more about how different uses of a numbing medication might affect pain levels while getting an IUD placed. The investigators are also studying participants opinions of their clinicians' empathy. The investigators are inviting patients who arrive at their clinic visit seeking an IUD. Usually, at University of California, San Diego (UCSD), for patients who have never delivered a baby, clinicians use a buffered paracervical block for before IUD placement. The purpose of this research study is to investigate whether a "buffered" (2 cc of sodium bicarbonate, 18 cc of 1% lidocaine) paracervical block (numbing medication given on both sides of the cervix) is effective in reducing pain during IUD placement in individuals with prior C-sections, the difference between buffered and unbuffered for nulliparous patients, and whether a medicated gel reduces pain with the paracervical block.
Conditions Studied
Interventions
- OTHER Sham Comparator
- DRUG Buffered Lidocaine
- DRUG Unbuffered lidocaine
- DRUG Xylocaine jelly 2%
- DRUG Surgilube
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2025-06-04 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06960317
The ClinicalTrials.gov registry entry for NCT06960317 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 204 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 72 other Contraception trials with a reported enrollment target (55% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Contraception appearing as the primary indexed condition, and to 5 interventions - of which Sham Comparator is the first listed.
NCT06960317 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06960317 about?
NCT06960317 is a clinical study titled "Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements". The goal of this research study is to learn more about how different uses of a numbing medication might affect pain levels while getting an IUD placed. The investigators are also studying participants opinions of their clinicians' empathy. The investigators are inviting patients who arrive at their...
What is the current status of trial NCT06960317?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2025-06-04. Estimated completion is 2028-06-30.
What conditions does trial NCT06960317 study?
This clinical trial studies the following conditions: Contraception, Pain, Acute, Anesthesia, Local.
What interventions are being tested in trial NCT06960317?
The interventions under investigation include: Sham Comparator (OTHER), Buffered Lidocaine (DRUG), Unbuffered lidocaine (DRUG), Xylocaine jelly 2% (DRUG), Surgilube (DRUG).
Who is sponsoring clinical trial NCT06960317?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06960317 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.